S49076 is an effective inhibitor of MET, AXL/MER, and FGFR1/2/3.
|Imatinib mesylate（甲磺酸伊马替尼） is a tyrosine kinase inhibitor with antineoplastic activity.||查看|
|Afatinib Dimaleate（阿法替尼双马来酸盐） is the dimaleate salt form of afatinib, an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.||查看|
|Osimertinib Mesylate(迈瑞替尼甲磺酸盐) is a Kinase Inhibitor. The mechanism of action of osimertinib is as a Kinase Inhibitor, and Cytochrome P450 3A Inhibitor, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 1A2 Inducer, and Breast Cancer Resistance Protein Inhibitor.||查看|
|Imatinib(伊马替尼) is an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase.||查看|
|Cabozantinib(卡博替尼) is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.||查看|